Higher leptin is associated with hypertension: The Multi-Ethnic Study of Atherosclerosis

Journal of Human Hypertension

Volumn 27, Issue 10, 2013, Pages 617-622

  Allison, M A ^a,b   Ix, J H ^a,b   Morgan, C ^a   McClelland, R L ^c   Rifkin, D ^a,b   Shimbo, D ^d   Criqui, M H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Howard Hughes Medical Institute   (United States)

Author keywords

Adipokine; Blood pressure; Ethnicity; Hypertension; Leptin

Indexed keywords

ADIPOCYTOKINE; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE PRESSURE; RACE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPONECTIN; ADIPOSITY; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; ETHNIC GROUPS; FEMALE; HUMANS; HYPERTENSION; LEPTIN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RESISTIN; RISK FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES; UP-REGULATION;

EID: 84884289092     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.24     Document Type: Article

References (38)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Obesity in the United States, 2009-2010. National Center for Health Statistics: Hyattsville, MD, 2012.
2. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89(6): 2595-2600.
3. Leong KS, Wilding JP. Obesity and diabetes. Best PracRes Clin Endocrinol 1999; 13(2): 221-237.
4. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. JHypertens 1994; 12(12): 1433-1437.
5. Jones DW. Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens 1996; 9(8): 50s-54s.
6. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10(29): 3621-3637.
7. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45(1): 9-14.
8. Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26(Suppl 2): S28-S38.
9. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2(3 Pt 2): 125S-132S.
10. Hall JE, Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23(3): 381-394.
11. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
12. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50(9): 1511-1525.
13. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multiethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156(9): 871-881.
14. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M et al. Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30(11): 2289-2296.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6): 499-502.
16. McClelland RLKR, Haessler J, Blumenthal RS, Goff DC. Estimation of risk factor associations when the response is influenced by medication use: an imputation approach. Stat Med 2008; 27(24): 5039-5053.
17. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24(19): 2911-2935.
18. Lilja M, Rolandsson O, Shaw JE, Pauvaday V, Cameron AJ, Tuomilehto J et al. Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. Int J Obes (Lond) 2010; 34(5): 878-885.
19. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14(6 Pt 2): S103-S115.
20. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334(5): 292-295.
21. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100(2): 270-278.
22. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24(5): 789-801.
23. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG. Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20(8): 1633-1641.
24. Hausberg M, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG. Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptormediated effect. Diabetes 2002; 51(8): 2434-2440.
25. Beltowski J, Wojcicka G, Borkowska E. Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 2002; 10(9): 939-946.
26. Beltowski J, Wj G, Gorny D, Marciniak A. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat - impaired effect in dietary-induced obesity. Med Sci Monit 2002; 8(6): BR221-BR229.
27. Villarreal D, Reams G, Freeman RH, Taraben A. Renal effects of leptin in normotensive, hypertensive, and obese rats. Am J Physiol 1998; 275(6 Pt 2): R2056-R2060.
28. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31(1 Pt 2): 409-414.
29. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 2001; 37(2 Part 2): 670-676.
30. Dobrian AD, Schriver SD, Lynch T, Prewitt RL. Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am J Physiol Renal Physiol 2003; 285(4): F619-F628.
31. Asferg C, Mogelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL et al. Leptin, not adiponectin, predicts hypertension in the copenhagen city heart study. Am J Hypertens 2009; 23(3): 327-333.
32. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11(1): 160-166.
33. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10(10 Pt 1): 1171-1174.
34. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84(10): 3686-3695.
35. Atabek ME, Kurtoglu S, Demir F, Baykara M. Relation of serum leptin and insulinlike growth factor-1 levels to intima-media thickness and functions of common carotid artery in children and adolescents with type 1 diabetes. Acta Paediatr 2004; 93(8): 1052-1057.
36. Lilja M, Rolandsson O, Norberg M, Soderberg S. The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord 2012; 10(2): 143-151.
37. Reseland JE, Anderssen SA, Solvoll K, Hjermann I, Urdal P, Holme I et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001; 73(2): 240-245.
38. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M. Sedentary behavior and adiposity-associated inflammation the multi-ethnic study of atherosclerosis. Am J Prev Med 2012; 42(1): 8-13.